Skip to main content
Clinical Trials/NCT05413109
NCT05413109
Recruiting
Not Applicable

COMPression of Left Main coRonary artEry in patientS With Pulmonary Arterial Hypertension aSymptomatIc fOr aNgina

IRCCS Azienda Ospedaliero-Universitaria di Bologna1 site in 1 country150 target enrollmentStarted: May 15, 2022Last updated:

Overview

Phase
Not Applicable
Status
Recruiting
Enrollment
150
Locations
1
Primary Endpoint
Incidence of extrinsic compression of the LMCA

Overview

Brief Summary

The prevalence of critical ab extrinsic compression of left main coronary artery (LMCA) is very high in patients with pulmonary arterial hypertension (PAH) symptomatic for angina (up to 40% according to a recent study of 121 patients with PAH). The element that most of all correlates with the degree of coronary stenosis is the diameter of the pulmonary artery (PA). In particular, a diameter ≥ 40 mm has a sensitivity of 83% and a specificity of 70% in patients with angina. Critical stenosis of LMCA is a risk factor for sudden death and in these condition percutaneous coronary angioplasty with stent implantation has proven to be a safe and effective long-term procedure. Preliminary data from a retrospective analysis of the registry of patients with PAH in Bologna (ARCA registry, 109/2016/U/Oss) highlights that even in PAH patients asymptomatic for angina, compression of LMCA can occur in up to 13% of patients and the main predictive parameter of compression was found to be a diameter ≥ 42 mm (with a sensitivity of 87% and a specificity of 77%). Performing a screening test by coronary-CT scan in all subjects suffering of PAH with a PA diameter ≥ 40 mm even if asymptomatic for angina could therefore help to identify patients with PAH at increased risk for sudden death at an early stage.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients with PAH (group 1 of World Health Organization pulmonary hypertension classification) who have undergone at least one pulmonary CT angiography with a PA trunk diameter ≥ 4 cm
  • Age ≥18 years
  • Asymptomaticity for angina pectoris or anginal equivalent

Exclusion Criteria

  • Severe chronic kidney disease \[Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) estimated glomerular filtration rate \<30 ml/min) or need for dialysis
  • Major allergy to iodinated contrast agent
  • Intolerance or allergy to acetylsalicylic acid or clopidogrel
  • History of stroke or transient ischemic attack in the last 6 months or a history of intracranial haemorrhage
  • Known cerebral arteriovenous malformation or aneurysm
  • Known moderate or severe hepatic insufficiency (Child Pugh B or C)
  • Thrombocytopenia (\<100.000/μL) or anemia (hemoglobin \<10 g/dL)
  • Active bleeding or factors which, in the investigator's judgment, significantly increase the risk of bleeding
  • Major surgery in the past 30 days
  • Cancer in the active phase

Outcomes

Primary Outcomes

Incidence of extrinsic compression of the LMCA

Time Frame: Baseline

To evaluate the incidence of extrinsic compression of the LMCA in patients with PAH and a PA diameter of at least 4 cm, asymptomatic for angina pectoris, subjected to a screening test by coronary CT angiography

Secondary Outcomes

  • Incidence of extrinsic compression of the LMCA by radiological pattern(Baseline)
  • Number of participants undergoing LMCA angioplasty with in-hospital complications(Baseline, 1 year)
  • Six minute walking test (6MWT)(Baseline, 6 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials